307 related articles for article (PubMed ID: 34445564)
1. Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives.
Bernardo A; De Nuccio C; Visentin S; Martire A; Minghetti L; Popoli P; Ferrante A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445564
[TBL] [Abstract][Full Text] [Related]
2. The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patients.
Visentin S; De Nuccio C; Bernardo A; Pepponi R; Ferrante A; Minghetti L; Popoli P
J Neurosci; 2013 Sep; 33(39):15388-93. PubMed ID: 24068806
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A
De Nuccio C; Bernardo A; Ferrante A; Pepponi R; Martire A; Falchi M; Visentin S; Popoli P; Minghetti L
Sci Rep; 2019 Jul; 9(1):9782. PubMed ID: 31278313
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of adenosine A2A receptors reduces intracellular cholesterol accumulation and rescues mitochondrial abnormalities in human neural cell models of Niemann-Pick C1.
Ferrante A; De Nuccio C; Pepponi R; Visentin S; Martire A; Bernardo A; Minghetti L; Popoli P
Neuropharmacology; 2016 Apr; 103():155-62. PubMed ID: 26631535
[TBL] [Abstract][Full Text] [Related]
5. The adenosine A
Ferrante A; Pezzola A; Matteucci A; Di Biase A; Attorri L; Armida M; Martire A; Chern Y; Popoli P
Neurobiol Dis; 2018 Feb; 110():1-11. PubMed ID: 29079454
[TBL] [Abstract][Full Text] [Related]
6. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.
Vance JE; Karten B
J Lipid Res; 2014 Aug; 55(8):1609-21. PubMed ID: 24664998
[TBL] [Abstract][Full Text] [Related]
8. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
Singhal A; Szente L; Hildreth JEK; Song B
Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967
[TBL] [Abstract][Full Text] [Related]
9. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
10. Niemann-Pick Disease Type C: from molecule to clinic.
Tang Y; Li H; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):132-40. PubMed ID: 19566836
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol in Niemann-Pick Type C disease.
Bi X; Liao G
Subcell Biochem; 2010; 51():319-35. PubMed ID: 20213549
[TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1-/- mouse brain.
Liao G; Cheung S; Galeano J; Ji AX; Qin Q; Bi X
Brain Res; 2009 May; 1270():140-51. PubMed ID: 19328188
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress: a pathogenic mechanism for Niemann-Pick type C disease.
Vázquez MC; Balboa E; Alvarez AR; Zanlungo S
Oxid Med Cell Longev; 2012; 2012():205713. PubMed ID: 22720116
[TBL] [Abstract][Full Text] [Related]
14. Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease.
Chen J; Soni RK; Xu Y; Simoes S; Liang FX; DeFreitas L; Hwang R; Montesinos J; Lee JH; Area-Gomez E; Nandakumar R; Vardarajan B; Marquer C
EBioMedicine; 2023 Jun; 92():104628. PubMed ID: 37245481
[TBL] [Abstract][Full Text] [Related]
15. The role of Niemann-Pick type C2 in zebrafish embryonic development.
Tseng WC; Johnson Escauriza AJ; Tsai-Morris CH; Feldman B; Dale RK; Wassif CA; Porter FD
Development; 2021 Apr; 148(7):. PubMed ID: 33722902
[TBL] [Abstract][Full Text] [Related]
16. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
17. Biophysical impact of sphingosine and other abnormal lipid accumulation in Niemann-Pick disease type C cell models.
Carreira AC; Pokorna S; Ventura AE; Walker MW; Futerman AH; Lloyd-Evans E; de Almeida RFM; Silva LC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158944. PubMed ID: 33892149
[TBL] [Abstract][Full Text] [Related]
18. Visualization of cholesterol deposits in lysosomes of Niemann-Pick type C fibroblasts using recombinant perfringolysin O.
Kwiatkowska K; Marszałek-Sadowska E; Traczyk G; Koprowski P; Musielak M; Lugowska A; Kulma M; Grzelczyk A; Sobota A
Orphanet J Rare Dis; 2014 Apr; 9():64. PubMed ID: 24775609
[TBL] [Abstract][Full Text] [Related]
19. The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.
Maceyka M; Milstien S; Spiegel S
FEBS J; 2013 Dec; 280(24):6367-72. PubMed ID: 23992240
[TBL] [Abstract][Full Text] [Related]
20. Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin.
Yu T; Lieberman AP
PLoS Genet; 2013 Apr; 9(4):e1003462. PubMed ID: 23593041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
